Subject: Intra-vitreal injections/implants
Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January to April 2016
If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].
Below are the number of intra-vitreal injections/implants that have been used between January and April 2016.
|Lucentis (ranibizumab) Injections||Avastin (bevacizumab) Injections||Eylea (aflibercept) Injections||Illuvien (Fluocinolone) Impants||Ozudex (Dexamethasone) Implants|